Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aysegul Atmaca

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Advances in Therapy|October 20, 2006
Effects of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and their combination on microalbuminuria in normotensive patients with type 2 diabetesAysegul Atmaca, Olcay Gedik
Advances in Therapy|February 6, 2007
Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosisAysegul Atmaca, Olcay Gedik
Advances in Therapy|November 22, 2007
Neuropad indicator test for diagnosis of sudomotor dysfunction in type 2 diabetesHabib Bilen, Aysegul Atmaca, Gungor Akcay
Diagnostic Cytopathology|February 27, 2016
Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsyBekir Kuru, Aysegul Atmaca, Mehmet Kefeli
Expert Review of Neurotherapeutics|April 30, 2013
Radiation-associated secondary brain tumors after conventional radiotherapy and radiosurgeryGulcin Cengiz Ecemis, Aysegul Atmaca, Deniz Meydan
Journal of Medical Case Reports|June 20, 2008
Pituitary hypoplasia and growth hormone deficiency in a woman with glycogen storage disease type Ia: a case reportSelcuk Dagdelen, Aysegul Atmaca, Ayfer Alikasifoglu, et al.
Menopause (New York, N.Y.)|February 19, 2008
Soy isoflavones in the management of postmenopausal osteoporosisAysegul Atmaca, Michael Kleerekoper, Miyase Bayraktar, et al.
Joint Bone Spine|August 11, 2007
Serum ghrelin levels but not GH, IGF-1 and IGFBP-3 levels are altered in patients with fibromyalgia syndromeBerna Tander, Aysegul Atmaca, Yuksel Aliyazicioglu, et al.
Endocrine|March 27, 2013
Evaluation of body weight, insulin resistance, leptin and adiponectin levels in premenopausal women with hyperprolactinemiaAysegul Atmaca, Birsen Bilgici, Gulcin Cengiz Ecemis, et al.
Endocrine|May 15, 2013
Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patientsSerkan Dogan, Aysegul Atmaca, Selcuk Dagdelen, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Advances in Therapy|October 20, 2006
Effects of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and their combination on microalbuminuria in normotensive patients with type 2 diabetesAysegul Atmaca, Olcay Gedik
Advances in Therapy|February 6, 2007
Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosisAysegul Atmaca, Olcay Gedik
Advances in Therapy|November 22, 2007
Neuropad indicator test for diagnosis of sudomotor dysfunction in type 2 diabetesHabib Bilen, Aysegul Atmaca, Gungor Akcay
Diagnostic Cytopathology|February 27, 2016
Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsyBekir Kuru, Aysegul Atmaca, Mehmet Kefeli
Expert Review of Neurotherapeutics|April 30, 2013
Radiation-associated secondary brain tumors after conventional radiotherapy and radiosurgeryGulcin Cengiz Ecemis, Aysegul Atmaca, Deniz Meydan
Journal of Medical Case Reports|June 20, 2008
Pituitary hypoplasia and growth hormone deficiency in a woman with glycogen storage disease type Ia: a case reportSelcuk Dagdelen, Aysegul Atmaca, Ayfer Alikasifoglu, et al.
Menopause (New York, N.Y.)|February 19, 2008
Soy isoflavones in the management of postmenopausal osteoporosisAysegul Atmaca, Michael Kleerekoper, Miyase Bayraktar, et al.
Joint Bone Spine|August 11, 2007
Serum ghrelin levels but not GH, IGF-1 and IGFBP-3 levels are altered in patients with fibromyalgia syndromeBerna Tander, Aysegul Atmaca, Yuksel Aliyazicioglu, et al.
Endocrine|March 27, 2013
Evaluation of body weight, insulin resistance, leptin and adiponectin levels in premenopausal women with hyperprolactinemiaAysegul Atmaca, Birsen Bilgici, Gulcin Cengiz Ecemis, et al.
Endocrine|May 15, 2013
Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patientsSerkan Dogan, Aysegul Atmaca, Selcuk Dagdelen, et al.
Pageof 4